Article • Future treaments discussed at senology congress
The year: 2034. Breast cancer patients benefit from perfectly personalised diagnostics and therapies. The tedium of follow-up treatments is a thing of the past, thanks to AI, augmented reality and robotics. Just a tale from the realm of science fiction, or could this soon be clinical reality? At the annual meeting of the German Senologic Society, Prof Dr Marc Thill from the Agaplesion Markus Hospital in Frankfurt cast a glance into the crystal ball, exploring the potential of new technologies, but also pointing out bottlenecks in diagnostics and professional personnel.